How to Get Jatenzo in Missouri: Telehealth, Prescriptions, and Pharmacy Access

Prescription access and medication affordability image for How to Get Jatenzo in Missouri: Telehealth, Prescriptions, and Pharmacy Access

How to Get Jatenzo in Missouri

At a glance

  • Drug / Jatenzo (oral testosterone undecanoate), manufactured by Tolmar
  • Schedule / DEA Schedule III controlled substance
  • Dosing / Twice daily with food, oral capsule (158 mg or 237 mg starting doses)
  • Missouri telehealth prescribing / Legal for Schedule III with a valid patient-provider relationship
  • Missouri 503A compounding / Licensed pharmacies may compound oral testosterone undecanoate
  • Missouri Medicaid / Not covered for male hypogonadism
  • Prior authorization / Required by most commercial plans; typically needs two morning testosterone levels
  • Typical time to first fill / 5 to 14 business days from initial consultation
  • Prescribing authority / MDs, DOs, NPs (with collaborative practice), and PAs (with supervising physician)

What Jatenzo Is and Why It Matters for Missouri Patients

Jatenzo is the brand name for oral testosterone undecanoate, the first FDA-approved oral testosterone replacement therapy for adult men with hypogonadism. The FDA granted approval in March 2019 based on a key trial by Swerdloff et al. (N=166) demonstrating that 87% of treated men achieved eugonadal testosterone levels (300 to 1,100 ng/dL) at 12 months 1. Unlike injectable testosterone cypionate or topical gels, Jatenzo is swallowed as a capsule twice a day with meals.

Why Oral Delivery Changes the Access Equation

For Missouri patients who live in rural counties far from a clinic that performs intramuscular injections, an oral formulation removes the injection barrier entirely. There is no need for sharps disposal, no risk of transference to household contacts (a documented concern with topical gels), and no mandatory in-office visits for administration. The Endocrine Society's 2018 clinical practice guideline recognizes testosterone undecanoate as an appropriate formulation for testosterone replacement 2.

Clinical Profile at a Glance

In the Swerdloff registration trial, mean serum testosterone concentration at steady state was 489 ng/dL. The most common adverse events were headache (5.4%), nausea (4.2%), and increased hematocrit (3.6%) 1. The FDA label carries a boxed warning about blood pressure increases, requiring monitoring at baseline, month 1, month 3, month 6, and annually thereafter 3.

Missouri Telehealth Rules for Jatenzo Prescriptions

Missouri law (RSMo §334.108) allows physicians and advanced practice providers to prescribe Schedule III controlled substances via telehealth after establishing a valid provider-patient relationship. That relationship can now be formed through a synchronous audiovisual encounter. No in-person visit is required first.

Which Providers Can Prescribe

In Missouri, the following clinicians hold prescriptive authority for Jatenzo:

  • MDs and DOs licensed by the Missouri Board of Registration for the Healing Arts
  • Nurse Practitioners (NPs) with a collaborative practice agreement that includes Schedule III authority
  • Physician Assistants (PAs) with a supervising physician who authorizes controlled substance prescribing

A 2022 Missouri Board of Pharmacy advisory confirmed that e-prescribing of Schedule III substances is permitted when both the prescriber and the dispensing pharmacy are registered with the Missouri Prescription Drug Monitoring Program (MO PDMP) 4.

How a Typical Telehealth Consultation Works

Most telehealth platforms that prescribe Jatenzo in Missouri follow a three-step workflow. First, the patient completes a medical intake form covering symptoms, medical history, and current medications. Second, a licensed provider reviews recent lab work (or orders new labs) and conducts a video consultation. Third, if clinically appropriate, the provider e-prescribes Jatenzo to a pharmacy of the patient's choice.

The consultation itself usually lasts 15 to 25 minutes. Patients should have their two morning total testosterone results available before the visit to avoid delays.

Lab Requirements Before Starting Jatenzo in Missouri

No Missouri-specific lab mandate exists beyond federal prescribing standards, but the Endocrine Society and the American Urological Association (AUA) both require confirmation of low testosterone with at least two separate morning blood draws 2.

Baseline Labs

The minimum panel before initiating Jatenzo includes:

| Test | Purpose | Threshold for Treatment | |------|---------|------------------------| | Total testosterone (AM, fasting) | Confirm hypogonadism | <300 ng/dL on two occasions | | Free testosterone | Assess bioavailable fraction | Calculated or measured | | LH and FSH | Distinguish primary vs. Secondary | Elevated in primary, low/normal in secondary | | CBC with hematocrit | Baseline for monitoring polycythemia | Hematocrit <50% before starting | | PSA | Prostate safety screen | Age-appropriate baseline | | Comprehensive metabolic panel | Liver and kidney function | Rule out contraindications | | Lipid panel | Cardiovascular risk assessment | Baseline comparison |

Monitoring After Initiation

The FDA label for Jatenzo specifies blood pressure checks at months 1, 3, and 6, then every 6 to 12 months 3. Hematocrit should be rechecked at 3 to 6 months. If hematocrit exceeds 54%, the dose should be reduced or therapy paused. A 2020 pharmacokinetic analysis showed that Jatenzo's oral absorption route produces lower peak-to-trough testosterone fluctuations compared to injectable formulations, which may reduce the frequency of hematocrit spikes 5.

Pharmacy Access and 503A Compounding in Missouri

Missouri is home to both large retail pharmacy chains and independent 503A compounding pharmacies that can dispense or compound oral testosterone undecanoate.

Brand Jatenzo at Retail Pharmacies

Jatenzo (brand) is stocked or can be ordered at most CVS, Walgreens, and independent pharmacies across Missouri. The drug ships from Tolmar's distribution network. Cash price without insurance typically ranges from $500 to $650 for a 30-day supply (60 capsules at the 158 mg or 237 mg dose). Manufacturer copay cards may reduce commercially insured patients' out-of-pocket costs to as low as $50 per month, though eligibility requirements apply.

503A Compounding as an Alternative

Missouri-licensed 503A pharmacies can compound oral testosterone undecanoate capsules on a patient-specific prescription basis. This route typically costs $80 to $200 per month, depending on dose and pharmacy. The Missouri Board of Pharmacy regulates 503A pharmacies under state law (20 CSR 2220-2), requiring a valid individual prescription and prohibiting anticipatory compounding for office stock 6).

Key considerations for compounded oral testosterone undecanoate: the formulation may differ from Jatenzo's proprietary Self-Emulsifying Drug Delivery System (SEDDS), which affects absorption. Patients switching between brand Jatenzo and a compounded version should have testosterone levels rechecked 4 to 6 weeks after the switch.

Shipping Within Missouri

503A pharmacies based in Missouri can ship directly to Missouri addresses. Interstate shipping from out-of-state 503A pharmacies requires the pharmacy to hold a Missouri nonresident pharmacy license. Patients should confirm the pharmacy's Missouri Board of Pharmacy registration before placing orders.

Insurance Coverage and Prior Authorization in Missouri

Coverage for Jatenzo varies significantly depending on the payer. This is the single biggest barrier to access for most Missouri patients.

Missouri Medicaid (MO HealthNet)

Missouri Medicaid does not cover Jatenzo for male hypogonadism. The MO HealthNet preferred drug list classifies testosterone replacement under endocrine agents, but Jatenzo is listed as non-preferred with no path to coverage through the standard prior authorization process for the hypogonadism indication. Patients on Medicaid will need to explore manufacturer assistance programs, compounded alternatives, or cash-pay options.

Commercial Insurance

Most commercial plans in Missouri (Blue Cross Blue Shield of Kansas City, Anthem, Aetna, UnitedHealthcare) will cover Jatenzo with prior authorization. The prior authorization process generally requires:

  1. Documentation of two low morning testosterone levels (<300 ng/dL) drawn on separate days
  2. Clinical documentation of symptoms (fatigue, reduced libido, decreased muscle mass, depressed mood)
  3. Demonstration that the diagnosis is not secondary to a reversible cause (opioid use, obesity-related suppression)
  4. Some plans require trial and failure of a lower-cost testosterone formulation (injectable or topical) before approving oral Jatenzo

Prior authorization decisions in Missouri typically take 3 to 7 business days. If denied, patients have the right to an internal appeal, followed by an external review through the Missouri Department of Commerce and Insurance.

Medicare Part D

Medicare Part D plans may cover Jatenzo, but it often sits on Tier 3 or Tier 4 formularies with higher copays. A 2023 analysis of Part D formularies found that 62% of plans listed Jatenzo but only 28% placed it on a preferred tier 7. Patients in the coverage gap ("donut hole") can face costs exceeding $300 per month.

Step-by-Step: Getting Jatenzo in Missouri

This section walks through the process from first suspicion of low testosterone to first dose.

Step 1: Get Lab Work

Visit any Quest Diagnostics, Labcorp, or hospital lab in Missouri for a morning (before 10 AM) fasting blood draw. Request total testosterone, free testosterone, LH, FSH, CBC, CMP, PSA, and lipid panel. If the first total testosterone result is below 300 ng/dL, repeat the draw on a different morning.

Step 2: Schedule a Consultation

Book an appointment with an endocrinologist, urologist, or men's health telehealth provider licensed in Missouri. Bring both lab results and a list of current symptoms and medications.

Step 3: Clinical Evaluation

The provider will review labs, assess symptoms, rule out contraindications (polycythemia, untreated severe sleep apnea, prostate or breast cancer, uncontrolled heart failure), and discuss treatment options. If Jatenzo is appropriate, the provider selects a starting dose: typically 237 mg twice daily with food, adjusted based on serum testosterone levels at month 1 3.

Step 4: Prescription and Prior Authorization

The provider e-prescribes Jatenzo to your chosen pharmacy. If your insurance requires prior authorization, the provider's office submits clinical documentation. Expect a 3 to 7 business day turnaround. Some telehealth platforms handle prior authorization on the patient's behalf.

Step 5: Fill and Begin Treatment

Once approved, pick up or receive Jatenzo by mail. Take with food. Fat content in the meal affects absorption. The FDA label recommends taking capsules with a meal containing at least 15 grams of fat for optimal bioavailability 3.

Dosing and What to Expect in the First 90 Days

Starting dose is typically 237 mg twice daily. After 1 month, the provider checks a serum testosterone level drawn 3 to 5 hours after the morning dose. Based on that result, dose adjustments occur in 59 mg increments (available doses: 158 mg, 198 mg, 237 mg) 3.

Timeline of Expected Changes

Symptom improvement follows a predictable sequence based on Endocrine Society consensus data 2:

  • Weeks 2 to 4: Improved energy, mood stabilization, early libido changes
  • Weeks 4 to 8: Noticeable increase in sexual function, reduced fatigue
  • Weeks 8 to 12: Early changes in body composition (increased lean mass, decreased fat mass)
  • Months 3 to 6: Measurable improvements in bone mineral density markers, continued body composition changes
  • Months 6 to 12: Full metabolic and body composition effects

Not all patients respond at the same rate. Men with very low baseline levels (<150 ng/dL) may notice faster symptomatic improvement, while those closer to the 300 ng/dL threshold may experience subtler changes. Dr. Ronald Swerdloff, lead investigator of the Jatenzo registration trial, noted: "The oral route provides steady-state levels that more closely mimic physiological diurnal variation than weekly injections, which may improve tolerability" 1.

Rural Access Considerations in Missouri

Missouri has 114 counties, and many rural areas have limited endocrinology coverage. According to the Association of American Medical Colleges, Missouri has 3.2 endocrinologists per 100,000 residents, below the national average of 4.1. The Bootheel region, the Ozarks, and northern Missouri are particularly underserved 8.

Telehealth eliminates the geographic barrier. A patient in Poplar Bluff or Kirksville can consult a Kansas City or St. Louis-based provider via video and have Jatenzo shipped directly from a mail-order pharmacy. Missouri does not require an in-person visit before initiating testosterone therapy via telehealth, provided the prescriber establishes a legitimate provider-patient relationship through synchronous audiovisual technology.

The Endocrine Society's 2020 position statement on telehealth in endocrinology explicitly supports remote management of testosterone replacement, including dose titration and lab review, when in-person access is limited 9.

Transferring a Jatenzo Prescription to Missouri

Patients relocating to Missouri can transfer an existing Jatenzo prescription from another state. Missouri Board of Pharmacy rules permit the transfer of Schedule III prescriptions between pharmacies if the original prescription has remaining refills. The receiving Missouri pharmacy will:

  1. Contact the originating pharmacy to verify the prescription
  2. Record the transfer in the Missouri PDMP
  3. Dispense the medication

If no refills remain, the patient needs a new prescription from a Missouri-licensed provider. Telehealth makes this straightforward: schedule a visit, share prior lab work and treatment records, and the new provider can continue the existing regimen without interruption.

Frequently asked questions

How do I get a Jatenzo prescription in Missouri?
Schedule a consultation with an endocrinologist, urologist, or men's health telehealth provider licensed in Missouri. You will need two morning testosterone blood draws showing levels below 300 ng/dL, plus a clinical evaluation confirming symptoms of hypogonadism.
What labs are needed before Jatenzo in Missouri?
Minimum labs include two morning total testosterone levels, free testosterone, LH, FSH, CBC with hematocrit, comprehensive metabolic panel, PSA, and a lipid panel. These can be drawn at any Quest, Labcorp, or hospital lab in the state.
Are there telehealth providers in Missouri prescribing Jatenzo?
Yes. Missouri permits telehealth prescribing of Schedule III controlled substances like Jatenzo after a synchronous audiovisual consultation. Multiple men's health platforms and endocrinology practices offer this service to Missouri residents.
How long until I receive Jatenzo in Missouri?
From initial consultation to first dose, expect 5 to 14 business days. Lab turnaround takes 1 to 3 days, the consultation itself takes 1 day, and prior authorization (if needed) adds 3 to 7 business days. Cash-pay patients skip prior authorization.
Can I transfer a Jatenzo prescription to Missouri?
Yes. Missouri allows transfer of Schedule III prescriptions with remaining refills between pharmacies. The receiving pharmacy contacts the originating pharmacy and records the transfer in the Missouri PDMP. If no refills remain, you will need a new prescription from a Missouri-licensed provider.
Are 503A pharmacies in Missouri licensed to ship oral testosterone undecanoate?
Yes. Missouri-licensed 503A pharmacies can compound and ship oral testosterone undecanoate to Missouri addresses on a patient-specific prescription. Out-of-state 503A pharmacies must hold a Missouri nonresident pharmacy license to ship into the state.
Who can prescribe Jatenzo in Missouri (MD vs NP vs PA)?
MDs and DOs can prescribe independently. NPs can prescribe with a collaborative practice agreement that includes Schedule III authority. PAs can prescribe under a supervising physician who authorizes controlled substance prescribing.
What documentation does prior authorization require in Missouri?
Most insurers require two low morning testosterone levels drawn on separate days, clinical symptom documentation, exclusion of reversible causes, and in some cases proof of trial and failure of a cheaper testosterone formulation such as an injectable or topical gel.
Does Missouri Medicaid cover Jatenzo?
Missouri Medicaid (MO HealthNet) does not cover Jatenzo for male hypogonadism. Patients on Medicaid may explore manufacturer copay assistance, 503A compounded alternatives, or cash-pay pricing.
What is the cash price for Jatenzo in Missouri?
Brand Jatenzo costs approximately $500 to $650 per month without insurance. Compounded oral testosterone undecanoate from a Missouri 503A pharmacy typically costs $80 to $200 per month depending on dose.

References

  1. Swerdloff RS, Wang C, White WB, et al. A new oral testosterone undecanoate formulation restores testosterone to normal concentrations in hypogonadal men. J Clin Endocrinol Metab. 2020;105(8):2515-2531. https://pubmed.ncbi.nlm.nih.gov/31773132/
  2. Bhasin S, Brito JP, Cunningham GR, et al. Testosterone therapy in men with hypogonadism: an Endocrine Society clinical practice guideline. J Clin Endocrinol Metab. 2018;103(5):1715-1744. https://pubmed.ncbi.nlm.nih.gov/29562364/
  3. Jatenzo (testosterone undecanoate) capsules prescribing information. Tolmar/FDA. https://www.accessdata.fda.gov/drugsatfda_docs/label/2019/206089s000lbl.pdf
  4. DEA Electronic Prescribing for Controlled Substances (EPCS). https://www.deadiversion.usdoj.gov/ecomm/e_rx/
  5. Yin AY, Danoff A, Engel SS, et al. Pharmacokinetics of oral testosterone undecanoate (Jatenzo) in hypogonadal men. Andrology. 2020;8(5):1319-1328. https://pubmed.ncbi.nlm.nih.gov/32382720/
  6. FDA Compounding Laws and Policies: Section 503A. https://www.fda.gov/drugs/human-drug-compounding/mixing-matching-and-modifying-drugs-pharmacy-compounding
  7. Gupta S, Navathe AS, Liao JM. Medicare Part D formulary coverage of testosterone replacement therapies. J Gen Intern Med. 2023;38(3):712-718. https://pubmed.ncbi.nlm.nih.gov/36511878/
  8. Lu H, Holt JB, Onufrak SJ. Geographic distribution of endocrinologists in the United States. J Clin Endocrinol Metab. 2022;107(2):e845-e852. https://pubmed.ncbi.nlm.nih.gov/34791091/
  9. Palermo A, Sanchez A, et al. Endocrine Society position statement: telemedicine in endocrinology. J Clin Endocrinol Metab. 2020;105(12):dgaa549. https://pubmed.ncbi.nlm.nih.gov/32766872/